CDX2 and colorectal carcinoma: This diagram shows that, in absolute numbers, eight CRCs have synchronous CDX2 expression loss and MLH1/PMS2 heterodimer deficiency, while only one CRC has synchronous CDX2 expression loss and MSH2/MSH6 heterodimer deficiency.